Ultragenyx (RARE) Ownership

35.40 ↓0.32 (-0.90%)
As of Market Close on November 28th, 2022.

Institutional Ownership

T. Rowe Price Associates, Inc. is the biggest individual institutional holder of Ultragenyx (RARE), owning a total of 10.8 million shares. Combined, the top 20 institutional holders of RARE own 71.93% of the company with a total of 50.4 million shares.

In the latest ownership report on September 30th 2022, the top 20 institutional holders increased their combined ownership of RARE by 2.1 million shares. 6 institutions bought 2,603,468 total additional shares and increased their ownership by an average of 19.80%. However 4 institutions sold 487,172 total shares and decreased their ownership by an average of 9.45%.

Overall this is a positive sign as the number of shares owned by the top 20 institutional holders of Ultragenyx increased by a net total of 2,116,296 in the latest quarter.

Institution Ownership Chart

Your browser does not support this chart.

Latest Institutional Ownership Changes

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
Vanguard Group Inc8.789%0.452%6,161,86627,7222022-09-30
Wellington Management Company LLP8.624%36.961%6,046,0381,631,5982022-09-30
Capital Research & Mgmt Co - Division 34.837%-0.625%3,391,082-21,3242022-09-30
State Street Corporation3.651%4.161%2,559,544102,2362022-09-30
Alkeon Capital Management, LLC3.155%-10.379%2,211,959-256,1712022-09-30
Avidity Partners Management LP2.926%38.669%2,051,600572,1002022-09-30
Goldman Sachs Group Inc1.442%17.570%1,011,188151,1132022-09-30
venBio Select Advisor LLC1.070%0.000%750,00002022-09-30
Bank of New York Mellon Corp1.049%-7.345%735,710-58,3222022-09-30
First Trust Advisors L.P.0.976%20.985%684,344118,6992022-09-30
Cadian Capital Management LP0.895%-19.440%627,203-151,3552022-09-30

Top Institutions

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
T. Rowe Price Associates, Inc.15.377%-9.295%10,780,156-1,104,6302022-06-30
Vanguard Group Inc8.789%0.452%6,161,86627,7222022-09-30
Wellington Management Company LLP8.624%36.961%6,046,0381,631,5982022-09-30
Federated Hermes Inc5.416%-4.781%3,797,089-190,6392022-06-30
Capital Research & Mgmt Co - Division 34.837%-0.625%3,391,082-21,3242022-09-30
ClearBridge Advisors, LLC4.047%-0.935%2,837,143-26,7782022-06-30
State Street Corporation3.651%4.161%2,559,544102,2362022-09-30
Alkeon Capital Management, LLC3.155%-10.379%2,211,959-256,1712022-09-30
Avidity Partners Management LP2.926%38.669%2,051,600572,1002022-09-30
RTW INVESTMENTS, LLC1.959%0.000%1,373,28402022-06-30
AllianceBernstein L.P.1.760%-10.143%1,234,124-139,3052022-06-30
FMR Inc1.652%-7.748%1,158,242-97,2822022-06-30
Rock Springs Capital Management LP1.559%6.315%1,093,03064,9212022-06-30
Citadel Advisors Llc1.451%-22.640%1,017,303-297,7292022-06-30
Goldman Sachs Group Inc1.442%17.570%1,011,188151,1132022-09-30
Geode Capital Management, LLC1.296%0.644%908,7135,8132022-06-30
venBio Select Advisor LLC1.070%0.000%750,00002022-09-30
Bank of New York Mellon Corp1.049%-7.345%735,710-58,3222022-09-30
First Trust Advisors L.P.0.976%20.985%684,344118,6992022-09-30
Cadian Capital Management LP0.895%-19.440%627,203-151,3552022-09-30

Mutual Fund Ownership

Vanguard Total Stock Mkt Idx Inv is the biggest individual fund holder of Ultragenyx (RARE), owning a total of 2 million shares. Combined, the top 20 mutual fund holders of RARE own 43.04% of the company with a total of 30.2 million shares.

In the latest ownership report on October 31st 2022, the top 20 fund holders increased their combined ownership of RARE by 96 thousand shares. 4 funds bought 96,327 total additional shares and increased their ownership by an average of 1.44%.

Overall this is a positive sign as the number of shares owned by the top 20 mutual funds holding Ultragenyx increased by a net total of 96,327 in the latest report.

Mutual Funds Chart

Your browser does not support this chart.

Latest Mutual Fund Ownership Changes

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
Vanguard Total Stock Mkt Idx Inv2.866%0.464%2,009,4709,2702022-10-31
Vanguard Small Cap Index2.449%1.648%1,717,01727,8412022-10-31
Hartford MidCap Y2.376%2.922%1,665,62447,2822022-10-31
SPDR® S&P Biotech ETF2.364%0.726%1,656,91611,9342022-10-31
Vanguard Explorer Inv2.128%0.000%1,491,68602022-10-31
First Trust NYSE Arca Biotech ETF1.591%0.000%1,115,60302022-10-31

Top Mutual Funds

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
Vanguard Total Stock Mkt Idx Inv2.866%0.464%2,009,4709,2702022-10-31
Vanguard Instl Ttl Stck Mkt Idx Tr2.853%2.027%2,000,20039,7362022-09-30
SD CollAccess Virtus NFJ Div Val A2.828%0.000%1,982,8601,982,8602022-03-31
Vanguard Small Cap Index2.449%1.648%1,717,01727,8412022-10-31
SD CollAccess Age 1 Advisor 0-8 A2.419%0.000%1,695,8141,695,8142022-03-31
Hartford MidCap Y2.376%2.922%1,665,62447,2822022-10-31
SPDR® S&P Biotech ETF2.364%0.726%1,656,91611,9342022-10-31
Federated Hermes Kaufmann Small Cap A2.211%0.944%1,550,00014,5002022-09-30
Federated Hermes Kaufmann Small Cap Grow2.211%0.944%1,550,00014,5002022-09-30
T. Rowe Price New Horizons2.150%-28.860%1,507,304-611,4812022-09-30
Federated Hermes Kaufmann R2.140%0.000%1,500,00002022-09-30
Federated Hermes Kaufmann Growth2.140%0.000%1,500,00002022-09-30
Vanguard Explorer Inv2.128%0.000%1,491,68602022-10-31
SD CollAccess Age 2 Advisor 9-10 A1.928%0.000%1,351,5241,351,5242022-03-31
Capital Group New Perspective Comp1.753%-0.156%1,228,978-1,9192022-09-30
American Funds New Perspective A1.753%-0.156%1,228,978-1,9192022-09-30
T. Rowe Price Health Sciences1.683%-24.241%1,179,514-377,4062022-09-30
SD CollAccess Age 5 Advisor 13 A1.625%0.000%1,138,8921,138,8922022-03-31
First Trust NYSE Arca Biotech ETF1.591%0.000%1,115,60302022-10-31
American Funds SMALLCAP World A1.578%0.000%1,106,21502022-09-30

Discussions

Please log in or register to share your thoughts.

Clean_Teoth

$RARE wow. The volume is so low today. Unreal

0 Like Report
millimaker

$RARE hows short doing? Keep short pls
we need your money.

0 Like Report